Characterize lipid nanoparticles with precision using NanoSight Pro to optimise delivery, stability, and performance in biopharma development.
Lipid nanoparticles have become a foundational technology in modern drug delivery, enabling breakthroughs across RNA therapeutics, gene editing systems, and targeted delivery of small molecules and biologics. Their ability to protect sensitive payloads and improve delivery efficiency has made them central to next-generation therapeutics.
However, the success of these systems depends on precise control at the nanoscale. Lipid nanoparticle performance is directly influenced by particle size, concentration, and structural integrity, all of which determine how effectively a therapeutic reaches its intended target. Even subtle variations can impact bioavailability, uptake, and overall efficacy.
These delivery systems are inherently complex. Formulation composition, processing conditions, and storage environments can all introduce variability into nanoparticle populations. Small changes in these parameters can lead to significant shifts in particle behaviour, often without obvious indicators at early stages.
This creates a critical analytical challenge. Traditional characterisation techniques often lack the resolution needed to detect early instability, emerging sub-populations, or low-level aggregation. As a result, important signals can be missed until they affect performance later in development.
With NanoSight Pro you can:
✔ Detect subtle changes in nanoparticle populations early
✔ Gain particle-level insight into size and concentration
✔ Generate reproducible data to support confident decisions
NanoSight Pro brings these critical details into focus, enabling earlier, more confident decision-making. Understanding this complexity is key, but it also reveals a deeper layer of hidden risks that can impact development if left unaddressed.
Works with OmniTrust: Malvern Panalytical's compliance solution for the regulated environment
Lipid nanoparticle systems are inherently complex, with performance driven by subtle interactions at the nanoscale. During formulation, processing, and storage, small and often undetectable changes can begin to reshape particle populations.
These early shifts rarely trigger immediate concern, yet they can have a profound impact on stability, delivery efficiency, and overall therapeutic performance if left unaddressed.
These risks are difficult to detect because they originate at the nanoscale, where even minor population changes can lead to significant biological consequences. Conventional ensemble techniques often average out these effects, masking early warning signals and limiting visibility into true sample complexity.
NanoSight Pro overcomes these limitations by delivering direct, particle-by-particle analysis. By tracking individual nanoparticles in suspension, it reveals hidden sub-populations, detects early aggregation, and quantifies concentration with precision. This enables researchers to identify and address critical issues earlier, reducing risk and supporting more confident development decisions.
Lipid nanoparticle systems often appear stable during early development, only to exhibit performance issues during scale-up, storage, or real-world application. Subtle changes in particle size distribution, concentration, or heterogeneity can influence cellular uptake, biodistribution, and payload delivery in ways that are not immediately apparent.
These issues frequently emerge late because traditional analytical methods do not capture the full complexity of nanoparticle populations. Early-stage aggregation, minor sub-populations, or shifts in concentration can go undetected until they manifest as reduced efficacy or stability failures.
NanoSight Pro addresses this challenge through nanoparticle tracking analysis, enabling direct visualisation and measurement of individual particles in suspension. This approach provides early detection of critical changes, supporting more informed decision-making and reducing the risk of late-stage failure.
Understanding early signs of instability is essential for maintaining lipid nanoparticle performance. Small changes in particle populations can signal the onset of aggregation or degradation, which may compromise delivery efficiency.
NanoSight Pro enables direct observation of these changes by tracking individual particles in real time. This allows researchers to identify emerging issues before they affect product quality or therapeutic outcomes.
With NanoSight Pro, you can:
✔ Detect early aggregation and subtle shifts in particle size distribution
✔ Identify low-abundance sub-populations within complex samples
✔ Monitor real-time changes linked to formulation and storage conditions
NanoSight Pro provides real-time, particle-level insight, enabling researchers to detect and understand these changes as they happen, supporting more informed decisions to protect product quality and therapeutic effectiveness.
Formulation development requires precise control over nanoparticle characteristics to achieve consistent delivery performance. Variations in composition or processing can significantly alter particle behaviour in biological environments.
By providing accurate measurements of particle size and concentration, NanoSight Pro supports data-driven optimisation of lipid nanoparticle systems. This enables teams to refine formulations with greater confidence and reproducibility.
With NanoSight Pro, you can:
✔ Measure particle concentration by size with high precision
✔ Optimise formulations to improve stability and bioavailability
✔ Ensure consistency across batches and process changes
NanoSight Pro enables precise, data-driven formulation development by accurately measuring nanoparticle size and concentration. This insight allows researchers to optimise lipid nanoparticle systems for improved stability, bioavailability and delivery performance, while maintaining consistency across batches and throughout process changes.
Lipid nanoparticle samples are rarely uniform. Heterogeneity within a sample can influence how particles interact with biological systems, affecting uptake, distribution, and overall therapeutic effectiveness.
NanoSight Pro reveals this complexity by distinguishing individual particle populations within the same sample. This deeper understanding enables more accurate characterisation and better control of nanoparticle behaviour.
With NanoSight Pro, you can:
✔ Characterise heterogeneous particle populations with clarity
✔ Distinguish between different size distributions within a sample
✔ Understand how nanoparticle behaviour evolves under real conditions
NanoSight Pro provides the clarity needed to characterise this heterogeneity by analysing individual particles within a sample, enabling researchers to distinguish between size distributions and understand how nanoparticle behaviour changes under real-world conditions. This deeper insight supports more accurate characterisation and greater control over formulation performances.
NanoSight Pro delivers the depth of characterisation required to fully understand and control lipid nanoparticle systems. By moving beyond ensemble measurements, it provides a clear, accurate picture of particle populations, enabling earlier insights and more reliable outcomes.
This level of analytical precision supports every stage of development, from formulation optimisation to scale-up and stability assessment.
With NanoSight Pro, biopharma teams can reduce uncertainty, improve reproducibility, and accelerate the path to successful delivery systems.
NanoSight Pro delivers:
✔ Particle-by-particle analysis using nanoparticle tracking analysis
✔ High-resolution measurement of particle size and concentration
✔ Detection of low-level aggregation and emerging sub-populations
✔ Insight into sample heterogeneity and population dynamics
✔ Real-time monitoring of changes during formulation and storage
✔ Improved batch-to-batch consistency and process control
✔ Early identification of stability risks
✔ Stronger analytical data to support development decisions
✔ Enhanced confidence in scale-up and manufacturing
✔ Accelerated development timelines through better insight
Gain the clarity needed to act with confidence at every stage of development. NanoSight Pro equips you with precise, particle-level insight to identify risks early, optimise performance with certainty, and progress lipid nanoparticle therapies faster with data you can trust.
Analyse ADC heterogeneity and stability with NanoSight Pro. Detect aggregation early and optimise conjugation with particle-level insight.
Characterise extracellular vesicles in cell therapy. Gain nanoscale insight into cell health, potency, and consistency with NanoSight Pro.
Analyse extracellular vesicles with precision using NanoSight Pro. Detect heterogeneity, quantify particles, and de-risk exosome development. Gain reproducible insight into vesicle behaviour in solution.
Characterise viral vectors with precision using NanoSight Pro. Measure size, concentration, and aggregation to support gene therapy development.
Characterize lipid nanoparticles with precision using NanoSight Pro to optimise delivery, stability, and performance in biopharma development.
Detect protein aggregation early with NanoSight Pro. Gain particle-level insight to improve stability, reduce risk, and accelerate biologics development.
Characterise nanomedicine particles with precision using NanoSight Pro. Improve stability, targeting, and development outcomes.
Discover how NanoSight Pro supports Quality Control and Quality Assurance by delivering reliable, reproducible data for regulatory compliant biologics and pharmaceutical development and manufacturing.
Gain reproducible insight into particle and molecular behaviour in vaccine systems. Detect instability, optimise formulations and accelerate vaccine development with Zetasizer.